JP Morgan Private Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $876K | Sell |
|
|||||
|
2023
Q2 | $751K | Sell |
|
|||||
|
2023
Q1 | $1.12M | Sell |
|
|||||
|
2022
Q4 | $1.32M | Buy |
|
|||||
|
2022
Q3 | $1.16M | Sell |
|
|||||
|
2022
Q2 | $1.09M | Buy |
|
|||||
|
2022
Q1 | $1.02M | Buy |
|
|||||
|
2021
Q4 | $567K | Sell |
|
|||||
|
2021
Q3 | $870K | Buy |
|
|||||
|
2021
Q2 | $750K | Buy |
|
|||||
|
2021
Q1 | $586K | Sell |
|
|||||
|
2020
Q4 | $787K | Sell |
|
|||||
|
2020
Q3 | $792K | Buy |
|
|||||
|
2020
Q2 | $901K | Buy |
|
|||||
|
2020
Q1 | $600K | Buy |
|
|||||
|
2019
Q4 | $306K | Buy |
|
|||||
|
2019
Q3 | $230K | Sell |
|
|||||
|
2019
Q2 | $944K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.89M | Sell |
|
|||||
|
2018
Q2 | $2.33M | Buy |
|
|||||
|
2018
Q1 | $1.96M | Buy |
|
|||||
|
2017
Q4 | $1.83M | Sell |
|
|||||
|
2017
Q3 | $1.45M | Buy |
|
|||||
|
2017
Q2 | $1.09M | Buy |
|
|||||
|
2017
Q1 | $1.02M | Buy |
|
|||||
|
2016
Q4 | $906K | Hold |
|
|||||
|
2016
Q3 | $1.19M | Sell |
|
|||||
|
2016
Q2 | $1.18M | Sell |
|
|||||
|
2016
Q1 | $1.05M | Sell |
|
|||||
|
2015
Q4 | $1.51M | Sell |
|
|||||
|
2015
Q3 | $1.36M | Sell |
|
|||||
|
2015
Q2 | $1.92M | Sell |
|
|||||
|
2015
Q1 | $1.68M | Sell |
|
|||||
|
2014
Q4 | $1.16M | Hold |
|
|||||
|
2014
Q3 | $815K | Hold |
|
|||||
|
2014
Q2 | $771K | Hold |
|
|||||
|
2014
Q1 | $837K | Buy |
|